With that said, our study was not without limitations and further studies into therapeutic window, dose, and underlying mechanisms are still requited to determine whether treatment with, or upregulation of, VEGF-A can be beneficial after mTBI and other forms of brain injury. The gene discussed is VEGFA; the disease is brain injury.